Sphero is a robotic ball that is controlled with a smartphone. Upcoming games incorporate the ball as a controller.
By John Roach
Fans of Sphero, the robotic ball that you control with your smartphone, will soon be able to use the ball to navigate fields of flying space rocks as they blast them apart with an anti-matter cannon, the makers of the gadget entice on their website.
The "coming soon" gaming app marks the latest evolution for the gadget that debuted at the 2011 Consumer Electronics Show?in Las Vegas. ?Then, it was a gee-whiz device that users controlled with their smartphone to roll it around a room.
This allowed games such as Sphero Golf, a hybrid between a virtual and real round. The phone serves as the golf club and the robot as the real-world ball. You can make a course anywhere and even play on an actual course should swinging your phone be less frustrating than a driver.
The Sphero-as-controller Space Fighter game, along with Chromo, a Simon Says-like color-matching-memory game, are getting buzz as the company makes media calls in New York. The folks at Business Insider got a preview at their offices on Thursday.?
Folks interested in getting their hands on Sphero can pre-order online.
When Orbotix decided to make a toy that can be used with smart phones, they choses the hardest object they could think of, a ball.
More on Sphero and other to control with a smartphone:
John Roach is a contributing writer for msnbc.com. To learn more about him, check out his website. For more of our Future of Technology series, watch the featured video below.
Ten years of war have given robot developers a chance to refine and improve their bots. Now the robots are finding all sorts of new jobs on the homefront.
New device removes stroke-causing blood clots better than standard treatment Public release date: 3-Feb-2012 [ | E-mail | Share ]
Contact: Amy Albin aalbin@mednet.ucla.edu 310-794-8672 University of California - Los Angeles Health Sciences
An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. Jeffrey L. Saver at the American Stroke Association's 2012 international conference in New Orleans on Feb. 3.
The SOLITAIRE Flow Restoration Device is among an entirely new generation of devices designed to remove blood clots from blocked brain arteries in patients experiencing stroke. It has a self-expanding, stent-like design and, once inserted into a clot using a thin catheter tube, it compresses and traps the clot. The clot is then removed by withdrawing the device, thus reopening the blocked blood vessel.
In the first U.S. clinical trial of SOLITAIRE, the device opened blocked vessels without causing symptomatic bleeding in or around the brain in 61 percent of patients. The standard Food and Drug Administrationapproved mechanical device a corkscrew-type clot remover called the MERCI Retriever was effective in 24 percent of cases.
The use of the new device also led to better survival three months after a stroke. There was a 17.2 percent mortality rate with the new device, compared with a 38.2 percent rate with the older one.
"This new device heralds a new era in acute stroke care," said Saver, the study's lead author and a professor of neurology at the David Geffen School of Medicine at UCLA. "We are going from our first generation of clot-removing procedures, which were only moderately good in reopening target arteries, to now having a highly effective tool. This really is a game-changing result."
About 87 percent of all strokes are caused by blood clots blocking a blood vessel supplying the brain. The stroke treatment that has received the most study is the FDAapproved clot-
busting drug known as tissue plasminogen activator, but this drug must be given within four-and-a-half hours after the onset of stroke symptoms, and even more quickly in older patients.
When clot-busting drugs cannot be used or are ineffective, the clot can sometimes be mechanically removed during, or beyond, the four-and-a-halfhour window. The current study, however, did not compare mechanical clot removal to drug treatment.
For the trial, called SOLITAIRE With the Intention for Thrombectomy (SWIFT), researchers randomly assigned 113 stroke patients at 18 hospitals to receive either SOLITAIRE or MERCI therapy within eight hours of stroke onset, between January 2010 and February 2011. The patients' average age was 67, and 68 percent were male. The time from the beginning of stroke symptoms to the start of the clot-retriever treatment averaged 5.1 hours. Forty percent of the patients had not improved with standard clot-busting medication prior to the study, while the remainder had not received it.
At the suggestion of a safety monitoring committee, the trial was ended nearly a year earlier than planned due to significantly better outcomes with the experimental device.
Other statistically significant findings included:
2 percent of SOLITAIRE-treated patients had symptoms of bleeding in the brain, compared with 11 percent of MERCI patients.
At the 90-day follow-up, overall adverse event rates, including bleeding in the brain, were similar for the two devices.
58 percent of SOLITAIRE-treated patients had good mental/motor functioning at 90 days, compared with 33 percent of MERCI patients.
The SOLITARE device also opened more vessels when used as the first treatment approach, necessitating fewer subsequent attempts with other devices or drugs.
"Nearly a decade ago, our UCLA Stroke Center team invented the first stroke retrieval device the MERCI Retriever and now we are pleased to have helped develop and successfully test a superior, next-generation clot removing device," said Dr. Reza Jahan, associate professor of radiology at UCLA and the study's principal neurointerventional investigator, who also led the pre-clinical studies. "It is exciting to have a highly effective new tool that can improve the outcomes for more stroke patients."
###
Additional co-authors included Dr. Elad Levy, Dr. Tudor G. Jovin, Dr. Blaise Baxter, Dr. Raul Nogueira, Dr. Wayne Clark, Dr. Ronald Budzik, Dr. Osama O. Zaidat and the SWIFT trial investigators.
Saver and Jahan received compensation from Covidien as scientific consultants for the design and conduct of the trial.
Covidien, the device manufacturer, funded the study. Although not yet approved in the United States, SOLITAIRE is used in Europe.
The UCLA Stroke Center, recognized as one of the world's leading centers for the management of cerebral vascular disease, treats simple and complex vascular disorders by incorporating recent developments in emergency medicine, stroke neurology, microneurosurgery, interventional neuroradiology, stereotactic radiology, neurointensive care, neuroanesthesiology and rehabilitation neurology. The program is unique in its ability to integrate clinical and research activities across multiple disciplines and departments. Founded in 1994, the UCLA Stroke Center is designated as a certified Primary Stroke Center by the national Joint Commission on Accreditation of Healthcare Organizations.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
New device removes stroke-causing blood clots better than standard treatment Public release date: 3-Feb-2012 [ | E-mail | Share ]
Contact: Amy Albin aalbin@mednet.ucla.edu 310-794-8672 University of California - Los Angeles Health Sciences
An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. Jeffrey L. Saver at the American Stroke Association's 2012 international conference in New Orleans on Feb. 3.
The SOLITAIRE Flow Restoration Device is among an entirely new generation of devices designed to remove blood clots from blocked brain arteries in patients experiencing stroke. It has a self-expanding, stent-like design and, once inserted into a clot using a thin catheter tube, it compresses and traps the clot. The clot is then removed by withdrawing the device, thus reopening the blocked blood vessel.
In the first U.S. clinical trial of SOLITAIRE, the device opened blocked vessels without causing symptomatic bleeding in or around the brain in 61 percent of patients. The standard Food and Drug Administrationapproved mechanical device a corkscrew-type clot remover called the MERCI Retriever was effective in 24 percent of cases.
The use of the new device also led to better survival three months after a stroke. There was a 17.2 percent mortality rate with the new device, compared with a 38.2 percent rate with the older one.
"This new device heralds a new era in acute stroke care," said Saver, the study's lead author and a professor of neurology at the David Geffen School of Medicine at UCLA. "We are going from our first generation of clot-removing procedures, which were only moderately good in reopening target arteries, to now having a highly effective tool. This really is a game-changing result."
About 87 percent of all strokes are caused by blood clots blocking a blood vessel supplying the brain. The stroke treatment that has received the most study is the FDAapproved clot-
busting drug known as tissue plasminogen activator, but this drug must be given within four-and-a-half hours after the onset of stroke symptoms, and even more quickly in older patients.
When clot-busting drugs cannot be used or are ineffective, the clot can sometimes be mechanically removed during, or beyond, the four-and-a-halfhour window. The current study, however, did not compare mechanical clot removal to drug treatment.
For the trial, called SOLITAIRE With the Intention for Thrombectomy (SWIFT), researchers randomly assigned 113 stroke patients at 18 hospitals to receive either SOLITAIRE or MERCI therapy within eight hours of stroke onset, between January 2010 and February 2011. The patients' average age was 67, and 68 percent were male. The time from the beginning of stroke symptoms to the start of the clot-retriever treatment averaged 5.1 hours. Forty percent of the patients had not improved with standard clot-busting medication prior to the study, while the remainder had not received it.
At the suggestion of a safety monitoring committee, the trial was ended nearly a year earlier than planned due to significantly better outcomes with the experimental device.
Other statistically significant findings included:
2 percent of SOLITAIRE-treated patients had symptoms of bleeding in the brain, compared with 11 percent of MERCI patients.
At the 90-day follow-up, overall adverse event rates, including bleeding in the brain, were similar for the two devices.
58 percent of SOLITAIRE-treated patients had good mental/motor functioning at 90 days, compared with 33 percent of MERCI patients.
The SOLITARE device also opened more vessels when used as the first treatment approach, necessitating fewer subsequent attempts with other devices or drugs.
"Nearly a decade ago, our UCLA Stroke Center team invented the first stroke retrieval device the MERCI Retriever and now we are pleased to have helped develop and successfully test a superior, next-generation clot removing device," said Dr. Reza Jahan, associate professor of radiology at UCLA and the study's principal neurointerventional investigator, who also led the pre-clinical studies. "It is exciting to have a highly effective new tool that can improve the outcomes for more stroke patients."
###
Additional co-authors included Dr. Elad Levy, Dr. Tudor G. Jovin, Dr. Blaise Baxter, Dr. Raul Nogueira, Dr. Wayne Clark, Dr. Ronald Budzik, Dr. Osama O. Zaidat and the SWIFT trial investigators.
Saver and Jahan received compensation from Covidien as scientific consultants for the design and conduct of the trial.
Covidien, the device manufacturer, funded the study. Although not yet approved in the United States, SOLITAIRE is used in Europe.
The UCLA Stroke Center, recognized as one of the world's leading centers for the management of cerebral vascular disease, treats simple and complex vascular disorders by incorporating recent developments in emergency medicine, stroke neurology, microneurosurgery, interventional neuroradiology, stereotactic radiology, neurointensive care, neuroanesthesiology and rehabilitation neurology. The program is unique in its ability to integrate clinical and research activities across multiple disciplines and departments. Founded in 1994, the UCLA Stroke Center is designated as a certified Primary Stroke Center by the national Joint Commission on Accreditation of Healthcare Organizations.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
ScienceDaily (Feb. 3, 2012) ? A painstakingly detailed investigation shows that mass extinctions need not be sudden events. The deadliest mass extinction of all took a long time to kill 90 percent of Earth's marine life, and it killed in stages, according to a newly published report.
Thomas J. Algeo, professor of geology at the University of Cincinnati, worked with 13 co-authors to produce a high-resolution look at the geology of a Permian-Triassic boundary section on Ellesmere Island in the Canadian Arctic. Their analysis, published Feb. 3 in the Geological Society of America Bulletin, provides strong evidence that Earth's biggest mass extinction phased in over hundreds of thousands of years.
About 252 million years ago, at the end of the Permian period, Earth almost became a lifeless planet. Around 90 percent of all living species disappeared then, in what scientists have called "The Great Dying." Algeo and colleagues have spent much of the past decade investigating the chemical evidence buried in rocks formed during this major extinction.
The world revealed by their research is horrific and alien: a devastated landscape, barren of vegetation and scarred by erosion from showers of acid rain, huge "dead zones" in the oceans, and runaway greenhouse warming leading to sizzling temperatures.
The evidence that Algeo and his colleagues are looking at points to massive volcanism in Siberia. A large portion of western Siberia reveals volcanic deposits up to five kilometers (three miles) thick, covering an area equivalent to the continental United States. And the lava flowed where it could most endanger life, through a large coal deposit.
"The eruption released lots of methane when it burned through the coal," he said. "Methane is 30 times more effective as a greenhouse gas than carbon dioxide. We're not sure how long the greenhouse effect lasted, but it seems to have been tens or hundreds of thousands of years."
A lot of the evidence ended up being washed into the ocean, and it is among fossilized marine deposits that Algeo and his colleagues look for it. Previous investigations have focused on deposits created by a now vanished ocean known as Tethys, a kind of precursor to the Indian Ocean. Those deposits, in South China particularly, record a sudden extinction at the end of the Permian.
"In shallow marine deposits, the latest Permian mass extinction was generally abrupt," Algeo said. "Based on such observations, it has been widely inferred that the extinction was a globally synchronous event."
Recent studies are starting to challenge that view.
Algeo and his co-authors focused on rock layers at West Blind Fiord on Ellesmere Island in the Canadian Arctic. That location, at the end of the Permian, would have been a lot closer to the Siberian volcanoes than sites in South China.
The Canadian sedimentary rock layers are 24 meters (almost 80 feet) thick and cross the Permian-Triassic boundary, including the latest Permian mass extinction horizon. The investigators looked at how the type of rock changed from the bottom to the top of the section. They looked at the chemistry of the rocks. They looked at the fossils contained in the rocks.
They discovered a total die-off of siliceous sponges about 100,000 years earlier than the marinemass extinction event recorded at Tethyan sites. Chemical clues, Algeo said, confirm that life on land was in crisis. Dying plants and eroding soil were being flushed into the ocean where the over-abundant nutrients led to a microbial feeding frenzy and the removal of oxygen -- and life -- from the late Permian ocean.
What appears to have happened, according to Algeo and his colleagues, is that the effects of early Siberian volcanic activity, such as toxic gases and ash, were confined to the northern latitudes. Only after the eruptions were in full swing did the effects reach the tropical latitudes of the Tethys Ocean.
The research was supported by the National Science Foundation, Canadian Natural Sciences and Engineering Research Council and the National Aeronautics and Space Administration Exobiology Program.
Recommend this story on Facebook, Twitter, and Google +1:
Other bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by University of Cincinnati. The original article was written by Greg Hand.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Note: If no author is given, the source is cited instead.
Disclaimer: Views expressed in this article do not necessarily reflect those of ScienceDaily or its staff.
Everyone has ?baggage? which they bring to their relationships from their childhood in their family of origin.
In fact, that is the place where we learn what relationships are and we develop patterns which we repeat in our adult relationships.
Everyone has some degree of dysfunctional relationship patterns? from the past, from mild to severe.
Some patterns are more obvious (physical or verbal abuse), some are more subtle (non verbal behavior conveys a message).
These patterns range from abandonment on one end to inundation on the other end and every combination of both in between.
A person with high abandonment issues (type A) will want more closeness than the person with higher inundation issues (type I).
The person who has inundation fears will experience the person with abandonment anxiety as ?needy? or ?clingy?, and distance themselves, thereby creating or triggering the exact repetition of the pattern.
The type A person will try even harder to get the closeness, and they are off and running. And of course the opposite is also true.
Type A will experience type I as the castle with the moat where the drawbridge is closed.
They will keep trying to cross the moat, but they will only get the person to come out of the castle, by quietly waiting, instead of further inundating them.
Each person is only trying to get their unmet needs from childhood met in the relationship. Instead they end up repeating them.
In any case, it is too much (perhaps even impossible) to expect a partner or spouse to fill your wounds from childhood, but people unconsciously choose a partner to do just that!
And it becomes attack-defend, ad?infinitum.
In a healthy relationship, knowing the other person?s developmental injuries, a person, will be consciously willing not to behave in ways that will trigger them.
To do this, a person must be healthy enough to give up his/her defensive reactions.
Here are a few examples.
Ineffective Communication
She said: ?You never listen to me?!
He said: ? I can?t stand the way that you are yelling at me?!
She said: ?I?m yelling because I am angry that I have had to say the same thing to you over and over?!
He said: ?I don?t listen because you are a nag?!
Beginning The Dialogue
Most people wait and ?put up? with the other person?s behavior until they are frustrated and angry, either avoiding confrontation or not wanting to hurt the other person.
This doesn?t work because the tone of voice (if not the volume) will reveal the resentment and anger and will be met defensively.
Both people need to learn to be courageous enough to take a risk and bring up a hurt feeling or a problematical situation for discussion before that situation has escalated into a volatile one.
Example: ?Can we set up a time to sit down and have a talk about something that?s been on my mind??
That might be interpreted by the receiver as the dreaded ?we have to talk? communication. Even so, try to convey, that you have positive intentions and are looking for a solution.
Then ask for a time for this to happen, so the other person is not put on the spot and has time to accommodate to the request.
?You Language? vs ?I Language?
Do not start a sentence with ?you?. The other person will feel criticized and become defensive. From there the ?discussion? will be series of attacks and defenses, going nowhere and escalating into a battle.
Starting a sentence with ?I? is expressing a feeling or opinion without blaming the other person (although they may feel blamed anyway). It takes practice to learn to speak ?I? language effectively.
Example: ?I feel hurt and angry when you don?t pay attention to what I am trying to tell you?.
Problem-when you say ? I feel (fill in the blank? when you (fill in the blank)-it is still ?you language? in disguise.
Better example: ?I want to share with you the way I am feeling right now?-Notice this is entirely about the speaker, just asking to be heard.
Active Listening, Being Heard and Mirroring
Once the dialogue has been initiated, the listener should be satisfied to just listen and not react from a personal place. The listener SHOULD begin their response with ?you? instead of ?I?.
Empathy and active listening is the first part of an effective communicating style. Empathy does not imply taking care of, feeling sorry for, agreeing with or apologizing to the other person.
It DOES imply hearing and UNDERSTANDING the emotional MEANING of what the speaker is saying.
It is not PARROTING, repeating or saying ?I hear you?.
Example:
Ineffective
She said: ?You didn?t return my calls?
He said: ?I was too busy at work. You should know that?.
She said: ?But I worry when you don?t call back?
He said: ?There you go again, I can never satisfy you?
Effective
She said: ?Honey, I?d like to talk to you, are you available now??
He said: ?Sure, what?s up? You look upset?
She said: ?I am upset. I felt really hurt when you didn?t return my calls today?
He said: ? I can understand that, you get concerned when I don?t call you back. Would it help if I can?t talk that I send you a text message letting you know I will call you back??
She said: ?Oh yes, that would be wonderful. Thanks Honey?
OR
He said: ?Not now, but I can spend some time later this evening?
She said ?Great, when can we do that??
He said: ? How about in an hour??
In the first case, she feels that her feelings are being received and? that he cares about her feeling, enough to listen. He doesn?t feel blamed or criticized or react defensively. He seems interested and receptive.
In the second case, if he can?t listen at that moment, he reassures her that he will make time to hear her later. That way, she does not feel dismissed or abandoned by him.
About the author
Dr. Marjorie Rand has?been a psychotherapist for 30 years, licensed in three states: California, Colorado and New Mexico, and have trained psychotherapists world-wide since 1986. Her training Institutes are located in Switzerland, Canada, Germany, Israel, South America and five in the United States.?
In addition to her practice as a Marriage and Family Therapist,?she is also a?somatic psychotherapist,?meditation teacher, supportive?yoga therapy teacher?and pre- and peri-natal psychologist.
To know more about Dr. Marjorie Rand, visit her website,?http://www.drrandbodymindtherapy.com/
Related posts:
Differences Between Good Communication And Bad Communication
Tagged as: Dr. Marjorie Rand, Effective vs Ineffective Communication, www.drrandbodymindtherapy.com/
New Health And Fitness.Org - Health Information You Can Use
Consult a Long Island dentist immediately if you have tooth decay. Tooth decay is a progressive condition resulting in the interaction of bacteria that naturally take place on the teeth and sugars in the everyday diet. Sugar causes a reaction in the bacteria, causing it to produce acids that digest the mineral in teeth, creating a cavity.
Dentists can eliminate the decay and fill the tooth utilizing a number of fillings, restoring the tooth to a healthy state. Nerve damage can result from serious decay and might need a crown. Avoiding unnecessary decay simply requires strict adherence to a dental hygiene regimen: brushing and flossing 2 times a day, regular dental checkups, diet control, and fluoride treatment. Practicing good hygiene puts a stop to unhealthy teeth and expensive treatment.
Fluoride is a substance that helps teeth become stronger and resistant to decay. Regularly drinking water treated with fluoride and brushing and flossing regularly ensures significantly lower cavities. Dentists can evaluate the level of fluoride in a primary drinking water source and recommend fluoride supplements (usually in tablets or drops), if necessary. Dentists are concerned about your comfort. Ask your dental provider if aromatherapy is available in the office, or if you can bring your own for your dental visit. Essential fragrance oils are available in health food stores, spas, and some grocery and drug store outlets. Research studies have noted that the use of aromatherapy has a significant positive effect on anxious dental patients. Two-thirds of the patients receiving aromatherapy were more calm and relaxed than those patients without exposure to the scented fragrance oils.
Loosing a single tooth may trigger adverse changes in your dentition ultimately affecting your oral health, ability to chew comfortably and your personal appearance. Your teeth support and rely on each other. When one or more teeth are missing, the remaining teeth can shift out of their normal position. Teeth adjacent to the space or from the opposite jaw will often drift or tilt. These teeth are often more susceptible to decay and gum disease and they are more difficult to clean properly. All of this shifting, drifting and wear will lead to changes in the bite and potentially, further tooth loss. The remaining dentition, with fewer teeth, is more susceptible to excessive functional stresses and tooth wear. Furthermore, the jawbone tends to atrophy or, ?shrink?, as a result of tooth loss. Ultimately, your ability to chew comfortably and your appearance may be affected. There are a lot of alternatives for replacing missing teeth.
If you have missing teeth, ask your Long Island dentist if dental implants are for you. The best alternative to date, to natural teeth! In addition to the general benefits of replacing a tooth, treatment with dental implants spares adjacent teeth and prevents further bone atrophy. Bridges restore appearance and function and are permanently fixed in position. In cases where adjacent teeth are heavily filled, or need crowns, a bridge might be the most sensible treatment option. Removable dentures are the cheapest alternative for replacing a number of missing teeth.
Whenever a New Yorker has missing teeth, they have to find the qualified dentist or periodontist who is an expert in painless Dental Implants in Long Island. Finding the best Dentist Long Island can certainly make a huge difference in getting the comfort, peace of mind and dental healthcare they deserve.
January 31st, 2012 ?|? Published in Basketball, Featured, Mount Mercy
KANSAS CITY, Mo. ? Mount Mercy won two of three games last week and maintained the 15th spot in this week?s NAIA Division II Women?s Basketball Coaches? Top 25 Poll, released last night by the national office.
The Mustangs (17-7, 9-3 MCC) started off last week with a 65-61 home loss to then-10th-ranked Grand View, but rebounded for road wins at Clarke (86-68) and William Penn (55-49). Mount Mercy remained at No. 15 in this week?s poll with 193 points. That?s one point ahead of 16th-ranked St. Thomas (Fla.) and 13 back of 14th-ranked Southwestern (Kan.).
Indiana Wesleyan (22-2) and Davenport (Mich.) shared the top spot this week with 363 points. Concordia (Neb.) (22-2) is third, followed by College of the Ozarks (Mo.) (19-3) and Morningside (18-6). Rounding out the top 10 is Concordia (Mich.) (20-4), Northwestern (17-5), Eastern Oregon (19-4), Grand View (19-5) and Briar Cliff (19-5).
Mount Mercy has a Midwest Collegiate Conference contest at Ashford on Wednesday at 5:30 p.m. at Kehl Arena in Clinton before returning home to face Waldorf on Think Pink Day on Saturday at 1:00 p.m. at Hennessey Recreation Center.
NEW YORK (AP) ? Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.
The pill is called Erivedge and is made by Genentech, a unit of Swiss drugmaker Roche. Erivedge is intended to treat locally advanced cancer for patients who are not candidates for surgery or radiation, and for patients whose cancer has spread to other parts of the body. The capsule is taken once per day.
Genentech said Erivedge is the first drug approved to treat advanced basal cell carcinoma. It said the drug will be available within one to two weeks.
The drug's label will warn that it is linked to fetal death and severe birth defects when it is used by pregnant women. The most common side effects of Erivedge include muscle spasms, hair loss, weight loss, diarrhea, fatigue, changes or loss in sense of taste, decreased appetite, constipation, and vomiting.
Curis Inc. of Lexington, Mass., which collaborated with Genentech on the drug, is getting a $10 million payment from Genentech now that the drug has been approved.
The approval comes ahead of schedule, as the Food and Drug Administration previously said it would make a decision on Erivedge by March 8. The drug was given a fast six-month review because there are no approved treatments for basal cell carcinoma.
![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 3-Feb-2012
Share ] 
KANSAS CITY, Mo. ? Mount Mercy won two of three games last week and maintained the 15th spot in this week?s NAIA Division II Women?s Basketball Coaches? Top 25 Poll, released last night by the national office.